PRESS RELEASE. Sciety has led a 36 MSEK funding round in the healthtech company Everdrone. The company operates and develops an autonomous drone service for time-critical medical transport, including the delivery of automated external defibrillators (AEDs) directly to patients in cardiac arrest. Everdrone’s customers include Västra Götaland Region, Region Stockholm and Region Normandie in France. The capital will be used to commercialise the business and further develop the company’s technology platform.
Each year, an estimated half a million people in Europe suffer sudden cardiac arrest. In Sweden, the figure is around 10,000 individuals, with the majority of cases occurring outside hospitals. Survival is directly dependent on how quickly defibrillation can be initiated. Although AEDs are increasingly available in public spaces, most cardiac arrests occur in the home, where access to life-saving equipment is often limited and ambulances frequently cannot arrive in time. Therefore, there is a significant need for solutions that can reach the patient quickly, at the location of the cardiac arrest.
Everdrone has developed a solution in which autonomous drones, integrated into the emergency response chain, deliver AEDs directly to the scene in parallel with ambulance dispatch. The technology combines proprietary drones with advanced software that enables autonomous deliveries in densely populated urban areas beyond visual line of sight – a regulatory demanding flight operation that only a handful of operators in Europe have achieved. The solution is optimised for time-critical medical transport and can be used in multiple types of acute medical situations. The system can also provide camera-based surveillance of incident sites to support emergency dispatch centre assessments.
The service is currently operational in Västra Götaland Region and is actively used in emergency responses in Normandy, France. The technology is now being implemented in Region Stockholm, with planned operational launch in 2026.
Everdrone has received significant international attention after becoming the first company in the world to contribute to saving a life during cardiac arrest using an autonomous drone. This has led to growing interest from regions, healthcare providers, emergency services and other stakeholders in emergency services.
Everdrone also sees a longer-term opportunity to offer its technology as a standalone service for organisations seeking to use drones for time-critical transport. The capital will be used to initiate commercialisation by validating the model within emergency services, and to further develop the technology platform for complementary services.
The funding round was led by Sciety, which also invested alongside the investor network Sciety Venture Partners. As a long-term capital partner in life science and digital health, Sciety contributes capital, industry expertise and an extensive network to accelerate growth in companies like Everdrone.
“Everdrone addresses a clear and well-documented need within emergency care. The company has established customer partnerships with several regions in Sweden and in France, and combines technological depth with clinical relevance. As a long-term capital partner, we look forward to supporting Everdrone in its next phase of commercialisation,” says Andreas Lindblom, Managing Partner at Sciety.
“Interest in drone-based solutions in emergency care is growing rapidly. With the capital from this funding round, we can continue to develop our technology platform and expand our presence across Europe. Sciety brings not only capital but also industry expertise, the right connections and greater visibility, making them a valuable partner in our continued development,” says Mats Sällström, CEO of Everdrone.
For more information, please contact:
Andreas Lindblom, Managing Partner, Sciety
andreas.lindblom@sciety.se | +46 70 375 73 73
Mats Sällström, VD, Everdrone
mats@everdrone.com | +46 702 28 10 95
About Sciety
Sciety is a long-term investment partner and investor in life science and health tech, with a focus on the Nordic region. We identify and invest in growth companies with the potential to create significant value for both investors and society, and with a clear path towards a future exit. We lead investment processes and invest alongside leading venture capital firms, family offices, and through our investor network, Sciety Venture Partners. Our goal is for growth companies within life science and digital health to scale and succeed, making scientific breakthroughs in medicine and technology accessible to people all over the world. For more information, visit www.sciety.com and follow us on LinkedIn.
About Everdrone
Everdrone AB is a leading provider of autonomous drone systems for emergency response and healthcare, headquartered in Gothenburg, Sweden. Its proprietary technology enables the extremely rapid delivery of life-saving medical equipment—such as automated external defibrillators (AEDs)—directly to the scene, while also providing real-time video support to emergency dispatchers. Known for safe, regulatory-compliant operations in urban areas, the company collaborates with public authorities to integrate its systems with existing emergency infrastructure. The company has been featured in leading medical journals including The Lancet and The New England Journal of Medicine, and gained international recognition as the first in the world to contribute to a life-saving intervention by delivering a defibrillator by drone to a cardiac arrest patient. The company is expanding internationally, with pilot programs and collaborations across Europe. For more information, visit everdrone.com and follow Everdrone on LinkedIn.
